For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Surface Oncology, Inc.

USPTO Granted Patents = 13

% Expired Patents = 23.1

Trademarks = 5

Forward Citations = 30

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Pamela M Holland (10 out of 13 patents)

Bianka Prinz (9 out of 60 patents)

Andrew Lake (9 out of 12 patents)

4. Scott C Chappel (9 out of 29 patents)

5. Jonathan Hill (7 out of 8 patents)

6. Matthew Rausch (5 out of 6 patents)

7. Alison Paterson (5 out of 5 patents)

8. Frank Grosveld (4 out of 12 patents)

9. Michael Warren (4 out of 4 patents)

10. Christine Miller (3 out of 4 patents)

11. Nels P Nielson (3 out of 13 patents)

12. Nadthakarn Boland (3 out of 8 patents)

13. Kevin Schutz (3 out of 4 patents)

14. John Bukowski (3 out of 4 patents)

15. Jennifer Symonds (3 out of 3 patents)

13 patents: Sort by Forward Citations

1. 12358978 - Anti-IL-27 antibodies and uses thereof (2025-07-15),

2. 12162941 - Anti-CD112R compositions and methods (2024-12-10),

3. 11655303 - Anti-CD39 antibody compositions and methods (2023-05-23),

4. 11332524 - Anti-IL-27 antibodies and uses thereof (2022-05-17),

5. 11312783 - Antibody molecules to CD73 and uses thereof (2022-04-26),

6. 11279758 - Anti-CD112R compositions and methods (2022-03-22),

7. 11214619 - Anti-CD112R compositions and methods (2022-01-04),

8. 10793637 - Antibodies that bind CD39 and uses thereof (2020-10-06),

9. 10738128 - Antibodies that bind CD39 and uses thereof (2020-08-11),

10. 10570201 - Anti-CD47 antibodies and methods of use (2020-02-25),

11. 10442858 - Anti-CD47 antibodies and methods of use (2019-10-15),

12. 9803016 - Anti-CD47 antibodies and methods of use (2017-10-31),

13. 9650441 - Anti-CD47 antibodies and methods of use (2017-05-16),

Surface Oncology, Inc. is a clinical-stage immuno-oncology company dedicated to developing next-generation therapies that target the tumor microenvironment (TME) to improve the lives of cancer patients. The company's proprietary platform focuses on discovering and developing novel therapies that modulate the immune system's response to cancer. Surface Oncology leverages its expertise in immunology, oncology, and translational medicine to advance its pipeline of potential therapies. With a mission to bring groundbreaking treatments to patients, Surface Oncology aims to transform the way cancer is treated.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Surface Oncology, Inc.

13 Patents

#192 in Cambridge, MA

#1,441 in Massachusetts

#23,808 in US

#44,950 in the World

Cambridge, MA, United States of America

Surface Oncology, Inc.

Forward Citations = 30

35 inventors:

Pamela M Holland (10 out of 13 patents)

Bianka Prinz (9 out of 60 patents)

Andrew Lake (9 out of 12 patents)

4. Scott C Chappel (9 out of 29 patents)

5. Jonathan Hill (7 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…